Skip to content
Neuro-ophthalmology

Compressive Visual Field Defect

1. What Are Compressive Visual Field Defects?

Section titled “1. What Are Compressive Visual Field Defects?”

Compressive visual field defects are a general term for visual field changes caused by compression of the visual pathway due to mass effect. Masses include tumors, aneurysms, hematomas, abscesses, and cysts.

The pattern of visual field defects varies greatly depending on which part of the visual pathway is compressed. Therefore, it is clinically very important to be able to estimate the location of the lesion from the pattern of visual field defects.

The most common cause of chiasmal lesions is pituitary adenoma. In children, craniopharyngioma is more frequent.

The incidence of orbital tumors in Japan is shown below.

Benign (top 5)ProportionMalignant (top 3)Proportion
Idiopathic orbital inflammation20%Malignant lymphomaMost common
Pleomorphic adenoma13%Lacrimal gland carcinoma
Hemangioma13%Metastatic tumor
Dermoid cyst10%
Reactive lymphoid hyperplasia10%

Compression of the optic nerve at any site can cause compressive optic neuropathy. The most common site of compression is the orbital apex.

Q What is the most common cause of compressive visual field defects?
A

At the optic chiasm, pituitary adenoma is the most common cause. Within the orbit, idiopathic orbital inflammation, pleomorphic adenoma, and hemangioma are the most frequent. In children, craniopharyngioma is common.

MRI and OCT images showing optic nerve sheath dilation and globe flattening
MRI and OCT images showing optic nerve sheath dilation and globe flattening
Sibony PA, et al. Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema. J Neuroophthalmol. 2021. Figure 1. PMCID: PMC7882012. License: CC BY.
A is an MRI image showing optic nerve sheath dilation and globe flattening, B and C are cross-sectional and vertically magnified OCT images, respectively. These correspond to the optic nerve compression findings discussed in the section “2. Main symptoms and clinical findings.”

Typically, it presents with slowly progressive vision loss in one eye. However, pituitary apoplexy or aneurysm rupture can cause acute onset.

  • Vision loss: Often unilateral. Rarely, acute bilateral vision loss may occur.
  • Dark areas in the visual field: Patients may not notice temporal visual field defects themselves.
  • Headache: Often associated with increased intracranial pressure.
  • Eye pain or periorbital pain: Due to traction on the trigeminal nerve or dural stretching.
  • Diplopia: Caused by ocular motility disturbance due to the tumor
  • Epileptic seizures: May occur in cases of intracranial lesions
  • Endocrine symptoms: Associated with pituitary lesions near the optic chiasm

Clinical Findings (Findings Confirmed by Physician Examination)

Section titled “Clinical Findings (Findings Confirmed by Physician Examination)”

Characteristic findings according to the compression site are shown below.

Chiasmal Lesion

Bitemporal hemianopsia: A classic finding caused by compression of crossing nasal fibers. Often asymmetric and incomplete.

Junctional scotoma: Central scotoma in the affected eye plus contralateral superior temporal visual field defect, suggesting an anterior chiasmal lesion.

Band optic atrophy: In the chronic phase, pallor of the temporal and nasal central optic disc.

Postchiasmal Lesions

Optic tract: Incongruous homonymous hemianopsia with RAPD. Near the cerebral peduncle, contralateral hemiparesis may occur.

Temporal lobe: Homonymous superior quadrantanopsia (“pie in the sky”). Reflects damage to Meyer’s loop.

Parietal lobe: Homonymous inferior quadrantanopia (“pie on the floor”). May be accompanied by Gerstmann syndrome and hemispatial neglect.

Occipital lobe: Congruous homonymous hemianopia. Macular sparing may be observed.

In compressive optic neuropathy, the optic disc initially swells and progresses to pallor and atrophy if treatment is delayed. Optical coherence tomography (OCT) detects localized thinning of the inner retinal layers corresponding to visual field defects.

In compressive optic neuropathy due to sphenoid fibrous dysplasia, glaucomatous-like cupping has been reported, with OCT showing thinning of the retinal nerve fiber layer (RNFL) in all quadrants and diffuse loss of the ganglion cell layer5).

Q What visual field defect patterns other than bitemporal hemianopia can occur?
A

At the anterior chiasm, junctional scotoma (central scotoma in the affected eye plus contralateral superior temporal defect) or Traquair junctional scotoma (monocular hemianopic defect) may occur. Posterior to the chiasm, homonymous hemianopia or quadrantanopia appears depending on the compression site.

The causes of compressive visual field defects are classified according to the site of compression along the visual pathway.

  • Neoplastic (frequent): Pituitary adenoma (most common), craniopharyngioma, meningioma2), optic glioma
  • Neoplastic (rare): Chordoma, germ cell tumor, leukemia, lymphoma, metastatic disease
  • Non-neoplastic: Sinus mucocele (sphenoid/ethmoid sinus), arachnoid cyst, Rathke’s cleft cyst, fibrous dysplasia
  • Aneurysm: Anterior communicating artery aneurysm, internal carotid artery aneurysm. May enlarge after flow diverter placement8)
  • Pituitary apoplexy: Causes acute visual field defects
  • Cavernous hemangioma/AVM: Impairs the visual pathway through both compression and ischemia

In adults, vascular/ischemic causes are common. In children, neoplastic causes are typical.

  • Hemorrhage: Hypertensive hemorrhage, amyloid angiopathy, vascular malformations
  • Primary brain tumors: Glioma, astrocytoma, oligodendroglioma
  • Metastatic tumors: Commonly originate from lung, breast, and melanoma
  • Thyroid eye disease: Enlargement of extraocular muscles compresses the optic nerve at the orbital apex
  • Infections: Infection of a paranasal sinus mucocele1), hydatid cyst9) (consider in endemic areas)
  • Sinonasal undifferentiated carcinoma (SNUC): Highly aggressive and can cause bilateral optic nerve compression6)
  • Nasopharyngeal carcinoma: Invades the orbital apex and compresses the optic nerve. Bilateral involvement is rare but has a poor prognosis7)
  • Pneumosinus dilatans: A rare condition in which abnormal expansion of the sphenoid sinus narrows the optic canal10)

Humphrey automated perimetry (24-2, 30-2, 10-2) is recommended for all patients with unexplained visual impairment. The pattern of visual field defects helps estimate the compression site and determine the imaging strategy.

Visual field testing is also useful for assessing disease progression and treatment efficacy, and should be performed over time.

Examination MethodAdvantagesMain Indications
CTExcellent for detecting bone lesions, calcifications, and bone destructionOrbital bone lesions, surgical planning
MRIBest for soft tissue evaluation. Gold standard.Tumor characterization, optic nerve assessment
PET/CTSearch for systemic metastasesStaging of malignant tumors

On T2-weighted MRI, it is useful for differentiating tumor characteristics. Solid tumors (such as lymphoma and meningioma) appear hypo- to isointense, while vascular and cystic tumors (such as cavernous hemangioma and dermoid cyst) appear hyperintense. Dynamic MRI is also useful in contrast-enhanced MRI, and delayed enhancement is characteristic of cavernous hemangioma.

  • CEA: Levels above 5.0 ng/mL suggest a high possibility of metastatic tumor.
  • IgG4: Useful for differentiating IgG4-related disease.
  • sIL-2R, LDH, β2-microglobulin: Markers for systemic dissemination of malignant lymphoma.
  • Endocrine tests: Performed when pituitary adenoma is suspected.

Optical coherence tomography (OCT) detects localized thinning of the inner retinal layers and is useful for early detection of mild optic atrophy. It can detect abnormalities earlier than visual field testing. It also helps in estimating prognosis after treatment.

Compressive optic neuropathy may present with glaucomatous cupping of the optic disc 5). The following findings suggest a non-glaucomatous etiology.

  • Age under 50 years
  • Headache or periorbital pain
  • Visual field defect affecting the vertical meridian
  • Rapid visual acuity decline
  • Pallor disproportionate to optic disc cupping
  • Asymmetric visual acuity loss and visual field defect

A report indicates that 6.5% of patients diagnosed with normal-tension glaucoma had clinically significant intracranial compressive lesions5).

Q How is glaucoma distinguished from compressive optic neuropathy?
A

Glaucoma presents with arcuate scotomas along the horizontal nerve fiber bundle, whereas compressive optic neuropathy is characterized by visual field defects that respect the vertical meridian. Pallor disproportionate to cupping, rapid vision loss, and onset before age 50 suggest a compressive lesion. If suspected, neuroimaging should be performed.

Most mass lesions compressing the visual pathway require surgery for both diagnosis (pathological confirmation) and treatment (relief of mass effect). Multidisciplinary collaboration (ophthalmology, neurosurgery, otolaryngology, endocrinology, etc.) depending on the cause is essential.

  • Pituitary adenoma: Surgery is the first choice except for prolactinomas. For prolactinomas, drug therapy such as bromocriptine or cabergoline is the mainstay. For other brain tumors, radiation therapy is also performed in addition to surgery.
  • Orbital tumor: Complete surgical resection is the standard for benign tumors. Pleomorphic adenoma of the lacrimal gland has a high recurrence rate with simple enucleation.
  • Malignant lymphoma: Highly radiosensitive. For localized orbital lymphoma, approximately 30 Gy is administered; for moderate to high grade, approximately 40 Gy.
  • Metastatic tumor: Hormone therapy may be effective for breast and prostate cancer. Systemic chemotherapy is also used in combination.
  • Thyroid eye disease: Steroid pulse or half-pulse therapy is first-line. After 1–3 courses, switch to oral administration. Orbital decompression is performed for steroid-resistant cases. With appropriate treatment, approximately 70% or more recover visual function.
  • Paranasal sinus mucocele: Emergency endoscopic sinus surgery for decompression is first-line1)4). Initial visual acuity is considered an important prognostic factor1).
  • Fibrous dysplasia: Surgical decompression is considered for symptomatic optic nerve compression. The indication for surgery in asymptomatic cases is debated5).

Once the compression of the optic chiasm is relieved, improvement in visual acuity and visual field can be observed. However, if optic atrophy is already evident, the visual prognosis is poor. Measurement of retinal thickness using OCT is useful for estimating prognosis after treatment.

In compressive optic neuropathy, a delay in intervention of 7 to 10 days or more is associated with an increased risk of irreversible visual impairment4).

Q Will vision recover if optic nerve compression is relieved?
A

Relief of compression can improve visual acuity and visual field. However, recovery is limited if optic atrophy has progressed. Better initial visual acuity indicates a better prognosis.

Anatomy and Fiber Tracts of the Visual Pathway

Section titled “Anatomy and Fiber Tracts of the Visual Pathway”

The visual pathway follows the route: retinal ganglion cellsoptic nerveoptic chiasm → optic tract → lateral geniculate nucleus (LGN) → optic radiation → striate cortex (V1).

At the optic chiasm, nasal retinal fibers cross to the opposite side, while temporal retinal fibers remain uncrossed and proceed ipsilaterally. Nasal fibers process the temporal visual field, and temporal fibers process the nasal visual field. Therefore, compression of crossing fibers causes temporal visual field defects, while compression of non-crossing fibers causes nasal visual field defects.

The Wilbrand knee (a structure where contralateral inferior nasal retinal fibers briefly enter the ipsilateral optic nerve before crossing) has been proposed as a cause of junctional scotoma, but its existence is debated.

Optic Radiation and Cortical Correspondence

Section titled “Optic Radiation and Cortical Correspondence”

The optic radiation emerges dorsally from the LGN and divides into two bundles.

  • Inferior fiber group (Meyer loop): Loops around the temporal lobe and transmits information from the upper visual field. Temporal lobe lesions cause homonymous superior quadrantanopia.
  • Superior fiber group (parietal bundle): Passes through the deep parietal lobe and transmits information from the lower visual field. Parietal lobe lesions cause homonymous inferior quadrantanopia.

The tip of the occipital cortex (macular representation area) receives dual blood supply from the middle cerebral artery and posterior cerebral artery, so macular sparing can occur with damage to a single vascular territory.

Multiple mechanisms are involved in the development of compressive optic neuropathy1).

  • Direct compression: Physical compression of the optic canal by a mass causes axonal damage.
  • Blood flow impairment: Compression disrupts blood supply to the optic nerve.
  • Inflammatory spread: The infected contents of the mucocele spread directly to the optic nerve sheath.

The effect of the tumor on the optic chiasm involves both direct compression and inflammatory blood flow disturbance.

In temporal lobe lesions caused by compressive lesions, the visual field defect shows a gradual isopter pattern compared to vascular lesions.

Blood flow to the LGN is supplied by the anterior choroidal artery and posterior choroidal artery. Segmental homonymous visual field defects occur depending on the site of damage to each small artery.

7. Latest Research and Future Perspectives (Research Stage Reports)

Section titled “7. Latest Research and Future Perspectives (Research Stage Reports)”

Treatment of Thyroid Eye Disease Compressive Optic Neuropathy with Teprotumumab

Section titled “Treatment of Thyroid Eye Disease Compressive Optic Neuropathy with Teprotumumab”

Teprotumumab (IGF-1R inhibitory monoclonal antibody) is the first approved drug for thyroid eye disease. Patients with compressive optic neuropathy (CON) were excluded from clinical trials, but efficacy has been reported in mild CON cases.

Chiou et al. (2021) reported two cases of mild CON due to thyroid eye disease that were resistant to IV steroids; after treatment with teprotumumab, visual field defects completely resolved in both cases 3). In the first case, resolution was observed after the third dose, and in the second case after the second dose.

Management of Aneurysm Enlargement After Flow Diverter Placement

Section titled “Management of Aneurysm Enlargement After Flow Diverter Placement”

Tsuei et al. (2022) reported a case of a 17 mm paraclinoid internal carotid artery aneurysm treated with a flow diverter (Pipeline embolization device). Despite complete angiographic occlusion, the aneurysm enlarged and caused compressive optic neuropathy 8). Visual fields improved after microsurgical optic nerve decompression and coagulation shrinkage of the aneurysm.

Endoscopic Endonasal Optic Nerve Decompression (ETOND)

Section titled “Endoscopic Endonasal Optic Nerve Decompression (ETOND)”

Zhou et al. (2024) performed endoscopic endonasal optic nerve decompression (ETOND) in four adolescent patients (mean age 12.75 years, all male) with visual impairment due to pneumosinus dilatans of the sphenoid bone 10). All cases were resistant to steroid pulse therapy, but visual improvement was achieved with ETOND.

Treatment Limitations of Compressive Optic Neuropathy Due to Malignant Tumors

Section titled “Treatment Limitations of Compressive Optic Neuropathy Due to Malignant Tumors”

Kong et al. (2022) reported a case of bilateral orbital apex infiltration due to nasopharyngeal carcinoma leading to loss of light perception 7). Despite treatment with steroids, chemotherapy, and radiotherapy, the right eye had no light perception and the left eye only hand motion. The optic nerve is considered to have the lowest recovery rate among cranial nerves 7).

Haydar et al. (2024) reported a case of compressive optic neuropathy caused by a hydatid cyst within the inferior rectus muscle in a 22-year-old male from Afghanistan 9). Complete excision and long-term albendazole therapy restored vision from 20/200 to 20/20.


  1. Che SA, Lee YW, Yoo YJ. Compressive optic neuropathy due to posterior ethmoid mucocele. BMC Ophthalmol. 2023;23:426.
  2. Teng Siew T, Mohamad SA, Sudarno R, et al. Unilateral proptosis and bilateral compressive optic neuropathy in a meningioma patient. Cureus. 2024;16(2):e53728.
  3. Chiou CA, Reshef ER, Freitag SK. Teprotumumab for the treatment of mild compressive optic neuropathy in thyroid eye disease: a report of two cases. Am J Ophthalmol Case Rep. 2021;22:101075.
  4. Deb アカントアメーバ角膜炎, Neena A, Sarkar S, et al. Bilateral compressive optic neuropathy secondary to sphenoid sinus mucocele mimicking bilateral retrobulbar neuritis. Saudi J Ophthalmol. 2021;35:368-370.
  5. Kiyat P, Top Karti D, Esen Ö, Karti Ö. Sphenoid bone dysplasia: a rare cause of compressive optic neuropathy mimicking glaucoma. Turk J Ophthalmol. 2023;53:70-73.
  6. Hassan MN, Wan Hitam WH, Masnon NA, et al. Compressive optic neuropathy secondary to sinonasal undifferentiated carcinoma in a young male. Cureus. 2021;13(10):e19042.
  7. Kong Y, Ng GJ. Rare early presentation of bilateral compressive optic neuropathy with complete vision loss from nasopharyngeal carcinoma. BMJ Case Rep. 2022;15:e248902.
  8. Tsuei YS, Fu YY, Chen WH, et al. Compressive optic neuropathy caused by a flow-diverter-occluded-but-still-growing supraclinoid internal carotid aneurysm: illustrative case. J Neurosurg Case Lessons. 2022;4(1):CASE22139.
  9. Haydar AA, Rafizadeh SM, Rahmanikhah E, et al. Orbital intramuscular hydatid cyst causing compressive optic neuropathy: a case report and literature review. BMC Ophthalmol. 2024;24:257.
  10. Zhou X, Xu Q, Zhang B, et al. Sphenoidal pneumosinus dilatans associated compressive optic neuropathy: a case series of four adolescent patients. Heliyon. 2024;10:e38763.

Copy the article text and paste it into your preferred AI assistant.